1. Home
  2. APRE vs CNEY Comparison

APRE vs CNEY Comparison

Compare APRE & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • CNEY
  • Stock Information
  • Founded
  • APRE 2006
  • CNEY 2018
  • Country
  • APRE United States
  • CNEY China
  • Employees
  • APRE N/A
  • CNEY N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • CNEY Major Chemicals
  • Sector
  • APRE Health Care
  • CNEY Industrials
  • Exchange
  • APRE Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • APRE 10.0M
  • CNEY 8.0M
  • IPO Year
  • APRE 2019
  • CNEY 2021
  • Fundamental
  • Price
  • APRE $1.89
  • CNEY $2.59
  • Analyst Decision
  • APRE Strong Buy
  • CNEY
  • Analyst Count
  • APRE 2
  • CNEY 0
  • Target Price
  • APRE $15.50
  • CNEY N/A
  • AVG Volume (30 Days)
  • APRE 50.1K
  • CNEY 31.4K
  • Earning Date
  • APRE 08-11-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • APRE N/A
  • CNEY N/A
  • EPS Growth
  • APRE N/A
  • CNEY N/A
  • EPS
  • APRE N/A
  • CNEY N/A
  • Revenue
  • APRE $1,284,475.00
  • CNEY $50,957,974.00
  • Revenue This Year
  • APRE N/A
  • CNEY N/A
  • Revenue Next Year
  • APRE N/A
  • CNEY N/A
  • P/E Ratio
  • APRE N/A
  • CNEY N/A
  • Revenue Growth
  • APRE 33.27
  • CNEY N/A
  • 52 Week Low
  • APRE $1.41
  • CNEY $2.38
  • 52 Week High
  • APRE $5.01
  • CNEY $40.00
  • Technical
  • Relative Strength Index (RSI)
  • APRE 55.82
  • CNEY 44.02
  • Support Level
  • APRE $1.60
  • CNEY $2.58
  • Resistance Level
  • APRE $2.22
  • CNEY $2.71
  • Average True Range (ATR)
  • APRE 0.17
  • CNEY 0.11
  • MACD
  • APRE 0.03
  • CNEY 0.02
  • Stochastic Oscillator
  • APRE 46.77
  • CNEY 64.24

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: